MDM2 and Human Malignancies: Expression, Clinical Pathology, Prognostic Markers, and Implications for Chemotherapy

By  

Current Cancer Drug Targets, Vol. 5, Iss. 1, 2005-02 ,pp. : 27-41

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinins and their Receptors in Human Malignancies

By  

Current Drug Targets, Vol. 7, Iss. 8, 2006-01 ,pp. : 1043-1052

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in the systemic therapy of advanced gastroesophageal malignancies

By Khamly Kenneth   Jefford Michael   Michael Michael   Zalcberg John  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 131-153

Informa Healthcare

Access to resources Recommend Favorite

Advances in Systemic Therapy for Gastroenteropancreatic Neuroendocrine Malignancies

By  

Current Clinical Pharmacology, Vol. 10, Iss. 4, 2015-10 ,pp. : 305-310

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting RSK2 in human malignancies

By Kang Sumin   Chen Jing  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite